Explore the latest in breast cancer, including recent guidelines and advances in screening, genetic testing, and precision treatment.
This cohort study examines whether mammographic density is associated with an increased risk of contralateral breast cancer or ipsilateral breast tumor recurrence among women.
This Viewpoint discusses
This cohort study examines the extent to which pathologic fractures are associated with major osteoporotic fracture events in women with invasive breast cancer who receive endocrine therapy.
This case-control and cross-sectional study investigates the association of premenopausal bilateral oophorectomy with mild cognitive impairment and cognitive test scores in later life.
This systematic review summarizes the patient-reported factors associated with older adults’ decisions to continue screening for breast, prostate, colorectal, and cervical cancer.
This cross-sectional study evaluates the representation of racial and ethnic minority groups in breast, prostate, lung, and colorectal cancer studies with a focus on precision medicine objectives.
This cohort study investigates the association between low levels of ERBB2 expression and progression-free survival among patients with HR+/ERBB2− metastatic breast cancer treated with CDK4/6 inhibitors.
This Viewpoint discusses the challenges of cardiovascular imaging in patients with breast cancer after reconstruction.
This cohort study examines short-term patient-reported changes in health-related quality of life in women with ductal carcinoma in situ undergoing magnetic resonance imaging for treatment planning.
This article in the JAMA Insights Women’s Health series discusses cancer-related cognitive impairment, including risks, management recommendations, and cognitive and behavioral treatments.
This case series analyzes the clinicopathologic characteristics and response to treatment of patients with persistent chemotherapy-induced alopecia after chemotherapy for breast cancer.
This review summarizes clinical aspects related to the application of neoadjuvant endocrine therapy in the treatment of hormone receptor–positive/ERBB2-negative breast cancer.
This randomized clinical trial examines the distribution and prognosis of residual cancer burden across high-risk phenotypic subtypes of breast cancer and by different treatment groups.
This cohort study uses linked registry data to investigate the biological and clinical progression of cancer associated with sociodemographic data and screening vs symptomatic detection in women with nonmetastatic invasive estrogen receptor–positive breast cancers.
This randomized clinical trial evaluates the effect of internal mammary node irradiation in regional nodal irradiation on disease-free survival among women with node-positive breast cancer in South Korea.
This cohort study assesses the rates and factors associated with outpatient low-value cancer screenings among nearly 6 million veterans who visited Veterans Health Administration primary clinics.
This randomized clinical trial compares the effectiveness of everolimus plus letrozole vs letrozole alone in premenopausal women with hormone receptor–positive, ERBB2-negative advanced breast cancer who experienced disease progression during selective estrogen receptor modulator treatment.
This cohort study uses data from the Hawaiʻi Tumor Registry to evaluate risk factors associated with developing invasive ipsilateral and contralateral second breast cancer among women from racial and ethnic minority populations with an initial diagnosis of ductal carcinoma in situ.
Customize your JAMA Network experience by selecting one or more topics from the list below.